Prostate Cancer – Daniel Petrylak, MD, and Robert Figlin, MD, discuss recent clinical advances in prostate cancer from ASCO GU

Prostate Cancer – Daniel Petrylak, MD, and Robert Figlin, MD, discuss recent clinical advances in prostate cancer from ASCO GU

Monday March 2, 2020

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Daniel Petrylak, MD, Professor of Medicine, Medical Oncology and Urology, Co-Leader, Cancer Signaling Networks, Yale Cancer Center, discuss the progress in prostate cancer presented at ASCO GU '20

Featured Videos

Daneng Li, MD, shares latest thoughts on checkpoint inhibitors being combines with TKIs

Richard Kim, MD, on the outcome on the IMBRAVE 150 study & the possibility of new treatment standard

Nevena Damjanov, MD, on impressions of the study combining cabozantinib with checkpoint inhibitors in advanced HCC patients